SENSEX: 72,400 ▲ 0.5% NIFTY: 21,800 ▲ 0.4% GOLD: 62,500 ▼ 0.2%
AlphaStreet Analysis

Dr Reddy’s Laboratories Ltd. Q1FY23; 6% growth in Revenue

Revenue for Q1 FY23 has increased by 6% YoY to ₹ 52,154 millions. Profits have grown by 108% YoY to ₹ 11,876 millions because Other Income has grown by 691% YoY to ₹ 8,539 millions from ₹ 1,079 millions.

In this quarter’s results, it was visible that the drastic increase in Other Income is the reason behind the staggering 108% growth in Profits. Other Income also helped in tackling the near term headwinds faced by the firm.

To further compare this quarter’s results to the past, check out this link.